Natural Alternatives International Announces Expanded Commitment to the CarnoSyn Brand
09 Oct 2015 --- Natural Alternatives International, Inc. (NAI), a global formulator and manufacturer of customized nutritional supplements, announced its expanded commitment to CarnoSyn, a studied, patent-protected beta-alanine ingredient for supporting an increase in muscle carnosine and athletic performance. As part of its commitment, NAI began to directly oversee the sales and distribution of CarnoSyn in the United States and abroad as of April 1st, 2015. NAI is showcasing CarnoSyn and previewing SR CarnoSyn - a new sustained release beta-alanine powder - at the upcoming SupplySide West conference in Las Vegas, Nevada on October 5-9, 2015.
NAI is a global manufacturer recognized for its strong commitment to health, scientific integrity and quality, which extends to its CarnoSyn brand. CarnoSyn is backed by 55 clinical studies which demonstrate the positive effects of CarnoSyn and SR CarnoSyn supplementation. The CarnoSyn brand is protected by NAI’s growing portfolio of 14 patents in the United States and 10 abroad, which guarantee quality and exclusivity for the brand.
“NAI is investing significant resources towards building, promoting and protecting the CarnoSyn brand, as well as supporting the upcoming launch of our new SR CarnoSyn sustained release beta-alanine powder”, said Mark A. LeDoux, NAI’s CEO and board chairman. “We’re very excited to expand the CarnoSyn portfolio of products and to work in partnership with both current and prospective partners to help drive business opportunities.”
CarnoSyn beta-alanine is a leading ingredient in sports nutrition formulations, supporting the synthesis of muscle carnosine, which acts as a buffer, delaying the onset of muscle fatigue and failure. Supplementing with CarnoSyn beta-alanine, which combines with histidine in the body to form carnosine, significantly increases the levels of carnosine in the muscle. Carnosine’s ability to buffer hydrogen ions keeps muscles contracting longer, which extends endurance, speeds muscle recovery, builds muscle strength and enhances peak performance capabilities.
SR CarnoSyn beta-alanine provides formulation flexibility via a sustained release profile, extending the benefits of beta-alanine to a much broader group of consumers with active lifestyles. SR CarnoSyn delivers higher levels of beta-alanine more comfortably in a single dose. SR CarnoSyn results in a sustained beta-alanine release that stays in the body longer for carnosine synthesis. The net effect is higher muscle retention of carnosine. SR CarnoSyn delivers much higher dosage levels than instant release CarnoSyn before reaching the typical paresthesia-sensation threshold.
In an effort to fortify the CarnoSyn brand and deliver additional value to its customers, NAI has expanded its commitment to the following areas of development:
•Continued Research and Development: NAI will continue to fund and support additional clinical studies to further strengthen substantiation, future product claims, and an expanded product line
•Robust B2B and B2C Marketing and Advertising Programs: NAI will commit substantial resources to help increase brand awareness and drive new business opportunities
•Vigorous Patent Protection: NAI will continue to dedicate resources to track and enforce compliance with its patent rights
•Inventory and Supply Control: NAI will continue to invest in robust inventory levels and supply chain support to guarantee material availability, ensure timely production and consistency in product safety and quality
NAI will exhibit in booth #1506 at SupplySide West, where it will preview a new sustained release powder delivery form, SR CarnoSyn, which delivers higher levels of beta-alanine more comfortably in a single dose.
